Survival Up With Nivolumab + Ipilimumab Versus Chemo for Metastatic CRC
Findings seen in patients with microsatellite-instability-high or mismatch-repair-deficient metastatic colorectal cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.